Financials data is unavailable for this security.
View more
Year on year ViroGates A/S 's revenues fell -45.01% from 10.15m to 5.58m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from a loss of 9.65m to a larger loss of 12.10m.
Gross margin | 69.49% |
---|---|
Net profit margin | -247.47% |
Operating margin | -251.18% |
Return on assets | -82.42% |
---|---|
Return on equity | -140.07% |
Return on investment | -89.49% |
More ▼
Cash flow in DKKView more
In 2023, ViroGates A/S increased its cash reserves by 62.25%, or 6.15m. Cash Flow from Financing totalled 18.32m or 328.11% of revenues. In addition the company used 12.18m for operations while cash from investing totalled 12.00k.
Cash flow per share | -2.91 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.45 |
---|---|
Tangible book value per share | 1.45 |
More ▼
Balance sheet in DKKView more
Current ratio | 11.74 |
---|---|
Quick ratio | 8.60 |
Total debt/total equity | 0.5689 |
---|---|
Total debt/total capital | 0.3626 |
More ▼